Validation of atrial fibrillation screening strategies in patients with ischemic heart disease using artificial intelligence electrocardiography (CVI ARO 21 Study)

Validation of atrial fibrillation screening strategies in patients with ischemic heart disease using artificial intelligence electrocardiography (CVI ARO 21 Study) - Validation of atrial fibrillation screening strategies in patients with ischemic heart disease using artificial intelligence electrocardiography (CVI ARO 21 Study)

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000061040

Enrollment

197

Registered

2026-04-01

Start date

2025-01-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic heart disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: (1) Hospitalized patients in order to perform CAG or PCI at our hospital and with AI-ECG enhanced AF risk score >= 0.8. (2) Out-hospital patients with AI-ECG enhanced AF risk score >= 0.8 and Suita risk score >=12.

Exclusion criteria

Exclusion criteria: Patients who do not consent to research participation.

Design outcomes

Primary

Measure	Time frame
Diagnostic rate of atrial fibrillation by long-term Holter ECG	—

Countries

Japan

Contacts

Public ContactNaomi Hirota

The Cardiovascular Institute Department of Cardiovascular Medicine

n-hirota@cvi.or.jp03-3408-2151

Outcome results